$ROL

Piper Sandler cuts Rollins stock price target on weak results By Investing.com

Piper Sandler cut its price target for Rollins Inc. (NYSE:ROL) to $46 from $72 while keeping an Overweight rating, citing weak pest-control results and residential weakness in May. Rollins reported Q2 adjusted EPS of $0.32 and revenue of $1.08B, and lowered 2026 guidance. The firm lowered earnings estimates and assumed a 35x 2027 EPS multiple.

Original reporting
Published Jul 24, 2026, 12:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ROL
Bearish
medium confidence
Mentioned
$ROL
Relevance
7/10
alphai data visualization · based on m.investing.com
Decision brief

The 30-second read

$ROLBearishMed
01

Why it matters

The PT reduction is driven by lower earnings estimates and a lower assumed valuation multiple, reflecting a more challenging near-term outlook and inconsistent results over the last three quarters.

02

Market read

Fresh sell-side valuation reset plus reiterated segment pressure increases the probability of continued negative revisions until residential demand and margins stabilize.

03

What to watch

Commercial pest control and termite services are described as strong, which could cushion earnings if residential stabilizes faster than estimates.

Relevance 7/10Novelty 6/10Timing: today’s analyst price-target cut following Rollins’ weak Q2 and guidance reset

Background

Piper Sandler maintained an Overweight rating but materially reduced its Rollins price target after another disappointing quarter and guidance cut.

Company-level read

Ticker impact

$ROLBearishMedium confidence
Context

Piper Sandler cut Rollins’ price target to $46 from $72 after weak residential results and lowered 2026 guidance.

Expected impact

Bias toward continued underperformance versus prior expectations until residential stabilizes; rallies may face resistance near lowered valuation assumptions.

Evidence & confidence

The article cites a specific PT reduction tied to lower earnings estimates, a lower 2027 multiple (35x), and guidance cuts, which typically pressures the stock and affects positioning.

Market effects

Signals broader pest-control demand volatility, especially in residential, and potential margin tradeoffs for digital-marketing-driven models.

No specific regional impact beyond US residential weakness implied by the guidance commentary.

Limited, as the news is company-specific to Rollins’ US-focused residential segment.

Counterpoint

Residential weakness may be partly weather-driven and could normalize as the article notes easier weather comparisons starting in Q4.

Key entities

  • Rollins Inc.

    Pest control company whose residential weakness and guidance cuts prompted the analyst PT reduction.

  • Piper Sandler

    Issued the price-target cut to $46 from $72 while keeping Overweight.

  • Wells Fargo

    Downgraded Rollins to Underweight from Equal Weight citing residential slowdown.

  • JPMorgan

    Downgraded to Neutral from Overweight citing near-term margin challenges.

Related articles

$ROLMedAI 8/10

Rollins shares drop 9.3% after Q2 earnings

Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.

$ROLMed

JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.

$ROLMedAI 8/10

Rollins Analysts Cut Their Forecasts After Downbeat Q2 Earnings - Rollins (NYSE:ROL)

Rollins Inc (NYSE:ROL) reported Q2 results after the close. Earnings were 32 cents per share versus a 34-cent consensus, and sales were $1.079 billion versus $1.092 billion expected. Shares fell 1.7% to $38.78 premarket. After the report, JP Morgan cut its target to $45 from $70 and downgraded to Neutral, while Wells Fargo cut to $32 from $46 and downgraded to Underweight.

$ROLMed

Wells Fargo says ditch this pest control stock as demand continues to soften

Wells Fargo downgraded Rollins (ROL) to underweight from equal weight and cut its price target to $32 from $46, citing softer residential pest-control demand. The bank cited headwinds including weather, potential impacts from LLMs, more aggressive competition, and more price-sensitive consumers. Rollins reported 5.7% organic growth, missed Q2 estimates, and lowered FY2026 guidance to about 6%.

$ROLMed

Why Rollins Stock Is Plummeting Lower Today

Rollins (ROL) shares fell about 10% after the company reported Q2 results. Sales rose 8% and beat expectations, but adjusted EPS grew 7%, below forecasts. Organic sales increased 6%, with management guiding 6% full-year organic growth plus 2-3 points from acquisitions. Bank of America cut its price target to $35 from $55.